|
1.
|
|
18 p, 3.7 MB |
The KMT2A recombinome of acute leukemias in 2023
/
Meyer, Claus (DCAL/Institute of Pharm. Biology. Goethe-University(Alemanya)) ;
Larghero, Patrizia (DCAL/Institute of Pharm. Biology. Goethe-University (Alemanya)) ;
Lopes, BA. (DCAL/Institute of Pharm. Biology. Goethe-University (Alemanya)) ;
Burmeister, Thomas (Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany) ;
Gröger, Daniela (Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin (Alemanya)) ;
Sutton, Rosemary (Molecular Diagnostics. Children's Cancer Institute. Lowy Cancer Research Centre. UNSW (Sidney, Austràlia)) ;
Venn, Nicola C. (Molecular Diagnostics. Children's Cancer Institute. Lowy Cancer Research Centre. UNSW (Sidney, Austràlia)) ;
Cazzaniga, Giovanni (University of Milano-Bicocca/Fondazione Tettamanti (Itàlia)) ;
Corral Abascal, Lilia (University of Milano-Bicocca/Fondazione Tettamanti (Itàlia)) ;
Tsaur, Grigory А. (Research Institute of Medical Cell Technologies (Ekaterinburg, Rússia)) ;
Fechina, Larisa G. (Research Institute of Medical Cell Technologies (Ekaterinburg, Rússia)) ;
Emerenciano, Mariana (Instituto Nacional de Câncer (INCA)(Rio de Janeiro, Brasil)) ;
Pombo-de-Oliveira, Maria S. (Instituto Nacional de Câncer (INCA)(Rio de Janeiro, Brasil)) ;
Lund-Aho, Tiina (Laboratory of Clinical Genetics, Fimlab Laboratories (Tampere, Finlàndia)) ;
Lundán, Tuija (University of Turku and Turku University Hospital (Turku, Finlàndia)) ;
Montonen, M. (University of Turku and Turku University Hospital (Turku, Finlàndia)) ;
Juvonen, Vesa (University of Turku and Turku University Hospital (Turku, Finlàndia)) ;
Zuna, Jan (Charles University and University Hospital Motol (Praga, República Txeca)) ;
Trka, Jan M. (Charles University and University Hospital Motol (Praga, República Txeca)) ;
Ballerini, Paola (Pierre et Marie Curie University (París, França)) ;
Lapillonne, Hélène (Pierre et Marie Curie University (París, França)) ;
Van der Velden, Vincent (University Medical Center Rotterdam (Països Baixos)) ;
Sonneveld, Edwin (Princess Máxima Center for Pediatric Oncology (Utrecht, Països Baixos)) ;
Delabesse, Éric C. M. (Institut Universitaire du Cancer de Toulouse (França)) ;
Capela de Matos, Roberto (National Cancer Institute (INCA) (Rio de Janeiro, Brasil)) ;
Silva, Maria Luiza (National Cancer Institute (INCA) (Rio de Janeiro, Brasil)) ;
Bomken, Simon (Newcastle University, Newcastle upon Tyne (Regne Unit)) ;
Katsibardi, Katerina (National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital (Atenes, Grècia)) ;
Keernik, Maria (Tartu University Hospital (Tartu, Estònia)) ;
Grardel, Nathalie (Department of Hematology, CHU Lille (França)) ;
Mason, J. (Newcastle University and the Great North Children's West Midlands Regional Genetics Laboratory (Regne Unit)) ;
Price, Richard (Newcastle University and the Great North Children's West Midlands Regional Genetics Laboratory (Regne Unit)) ;
Kim, J. (DCAL/Institute of Pharm. Biology. Goethe-University (Alemanya)) ;
Eckert, Cornelia (Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin (Alemanya)) ;
Lo Nigro, Luca (Centro di Riferimento Regionale di Ematologia ed Oncologia Pediatrica, Azienda Policlinico "G. Rodolico" (Catània, Itàlia)) ;
Bueno, Clara (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Menéndez Bujan, Pablo (Centro di Riferimento Regionale di Ematologia ed Oncologia Pediatrica, Azienda Policlinico "G. Rodolico" (Catània, Itàlia)) ;
Zur Stadt, Udo (University Medical Center Hamburg-Eppendorf (Hamburg, Alemanya)) ;
Gameiro, Paula (Instituto Português de Oncologia, Departament of Hematology (Lisboa, Portugal)) ;
Sedek, Łukasz (Medical University of Silesia (Zabrze, Polònia)) ;
Szczepanski, Tomasz (Medical University of Silesia (Zabrze, Polònia)) ;
Bidet, A. (Laboratoire d'Hématologie Biologique, CHU Bordeaux (França)) ;
Marcu, Victoria (Hematology Laboratory, Sheba Medical Center, Tel-Hashomer, Israel) ;
Shichrur, Keren (Schneider Children's Medical Center of Israel, Petah Tikva, Israel) ;
Izraeli, Shai (Tel Aviv University, Tel Aviv, Israel) ;
Madsen, Hans Ole (Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark) ;
Schäfer, Beat (University Children's Hospital Zurich (Zúric, Suïssa)) ;
Kubetzko, Susanne (University Children's Hospital Zurich (Zúric, Suïssa)) ;
Kim, Rathana (Université Paris Cité (França)) ;
Clappier, Emmanuelle (Université Paris Cité (França)) ;
Trautmann, Heiko (University Hospital Schleswig-Holstein (Kiel, Alemanya)) ;
Brüggemann, Monika (University Hospital Schleswig-Holstein (Kiel, Alemanya)) ;
Archer, Paul (Bristol Genetics Laboratory, North Bristol NHS Trust (Bristol, Regne Unit)) ;
Hancock, Jeremy P. (Bristol Genetics Laboratory, North Bristol NHS Trust (Bristol, Regne Unit)) ;
Alten, Julia (University Hospital Schleswig-Holstein (Kiel, Alemanya)) ;
Möricke, Anja (University Hospital Schleswig-Holstein (Kiel, Alemanya)) ;
Stanulla, Martin (Department of Pediatrics, MHH (Hanover, Alemanya)) ;
Lentes, Jana (Medical School Hannover (Alemanya)) ;
Bergmann, Anke K. (Medical School Hannover (Alemanya)) ;
Strehl, Sabine (St. Anna Children's Cancer Research Institute (CCRI) (Vienna, Àustria)) ;
Köhrer, Stefan (St. Anna Children's Cancer Research Institute (CCRI) (Vienna, Àustria)) ;
Nebral, Karin (St. Anna Children's Cancer Research Institute (CCRI) (Vienna, Àustria)) ;
Dworzak, Michael Norbert (St. Anna Children's Cancer Research Institute (CCRI) (Vienna, Àustria)) ;
Haas, Oskar A. (St. Anna Children's Cancer Research Institute (CCRI) (Vienna, Àustria)) ;
Arfeuille, Chloe (Hopital Robert Debré (París, França)) ;
Caye Eude, Aurélie (Hopital Robert Debré (París, França)) ;
Cavé, Hélène (Hopital Robert Debré (París, França)) ;
Marschalek, Rolf (Goethe-University (Alemanya))
Chromosomal rearrangements of the human KMT2A/MLL gene are associated with de novo as well as therapy-induced infant, pediatric, and adult acute leukemias. Here, we present the data obtained from 3401 acute leukemia patients that have been analyzed between 2003 and 2022. [...]
2023 -  10.1038/s41375-023-01877-1
Leukemia, Vol. 37 Núm. 5 (may 2023) , p. 988-1005
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
